Harvard Bioscience (HBIO) SEC Filings: History & Chart

Harvard Bioscience, Inc.(HBIO)

Medical - Instruments & Supplies · Holliston, MA

$8.61+0.11 (+1.24%)

Delayed quote: Oct 6, 2026, 2:22 PM EDT

About Harvard Bioscience, Inc.

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through websites and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic laboratories. It primarily sells its products under the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS, Warner, DSI, Panlab, Hugo Sachs, and Buxco brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts.

Holliston, MA

328 employees

www.harvardbioscience.com

Healthcare / Medical - Instruments & Supplies

Sector: Healthcare
Industry: Medical - Instruments & Supplies
CEO: John D. Duke

View full financials

Form	Filing Date	Accepted	Document
SC 13G/A	Sep 22, 2026	Sep 22, 2026	View filing
10-Q	Aug 11, 2026	Aug 11, 2026	View filing
8-K	Aug 11, 2026	Aug 11, 2026	View filing
8-K	Aug 11, 2026	Aug 11, 2026	View filing
4	Jun 12, 2026	Jun 12, 2026	View filing
4	Jun 11, 2026	Jun 11, 2026	View filing
4	Jun 11, 2026	Jun 11, 2026	View filing
4	Jun 11, 2026	Jun 11, 2026	View filing
4	Jun 11, 2026	Jun 11, 2026	View filing
S-8	Jun 10, 2026	Jun 10, 2026	View filing
8-K	Jun 2, 2026	Jun 2, 2026	View filing
SD	May 27, 2026	May 27, 2026	View filing
SC 13G/A	May 14, 2026	May 14, 2026	View filing
10-Q	May 12, 2026	May 12, 2026	View filing
8-K	May 12, 2026	May 12, 2026	View filing
8-K	May 12, 2026	May 12, 2026	View filing
DEFA14A	Apr 21, 2026	Apr 21, 2026	View filing
DEF 14A	Apr 21, 2026	Apr 21, 2026	View filing
4	Apr 1, 2026	Apr 1, 2026	View filing
4	Apr 1, 2026	Apr 1, 2026	View filing
4	Mar 23, 2026	Mar 23, 2026	View filing
SC 13D	Mar 23, 2026	Mar 23, 2026	View filing
4	Mar 18, 2026	Mar 18, 2026	View filing
4	Mar 18, 2026	Mar 18, 2026	View filing
4	Mar 17, 2026	Mar 17, 2026	View filing
8-K	Mar 17, 2026	Mar 17, 2026	View filing
10-K	Mar 13, 2026	Mar 13, 2026	View filing
8-K	Mar 12, 2026	Mar 12, 2026	View filing
8-K	Mar 10, 2026	Mar 10, 2026	View filing
8-K	Mar 6, 2026	Mar 6, 2026	View filing

SEC Filings

Recent Filings